Compare ARK Genomic Revolution ETF (ARKG) vs Prologis Inc (PLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Prologis Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.36, while Prologis Inc trades at $139.28 (market cap $132.57B). The key difference: Prologis Inc pays a 3.07% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Prologis Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | PLD | |
|---|---|---|
Sector | Sector/Thematic | Real Estate |
52-Week High | $44.55 | $149.96 |
52-Week Low | $24.02 | $104.81 |
Market Cap | — | $132.57B |
Enterprise Value | — | $167.31B |
Dividend Yield | — | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Prologis Inc
Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $70 billion of third-party AUM. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.
Read more on PLD →
